Ginkgo Reaction Time Meta-analysis: What the Evidence Says

Quick Answer

Ginkgo Reaction Time Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Severe AMS, however, is associated with the development of other high-altitude illnesses, such as high-altitude cerebral edema (HACE) and/or high-altitude pulmonary edema (HAPE), both potentially life-threatening and characterized by vasogenic edema, altered vascular permeability, and neurological or respiratory dysfunction. [Pena Eduardo (2026); evidence level 1]
• Over the years, the prevalence of AMS has increased considerably, as it has been determined that not only mountaineers or climbers are affected, but also individuals working under these conditions in rotational shifts between high-altitude environments and sea level, involving activities such as mining, border security, healthcare, and tourism (;). [Pena Eduardo (2026); evidence level 1]
• It should be emphasized that ARCD denotes a physiological decline in cognitive function associated with advancing age; its severity does not meet the diagnostic threshold for mild cognitive impairment (MCI), which represents a transitional state between normal aging and dementia. [Feng Xueyan (2026); evidence level 1]
• However, current pharmacological treatments, such as cholinesterase inhibitors, have limited efficacy and are associated with side effects. [Feng Xueyan (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For ginkgo reaction time meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Pena Eduardo (2026). Systematic review and meta-analysis of antioxidant treatment in patients with acute mountain sickness induced by high altitude exposure. DOI: 10.3389/fphys.2026.1779008. PMCID: PMC13006292. PMID: 41878732. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13006292/
• Feng Xueyan (2026). The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials. DOI: 10.3389/fphar.2025.1672171. PMCID: PMC12864429. PMID: 41640686. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12864429/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.